(VIANEWS) – Maiden Holdings, Ltd. (MHLD), Alexandria Real Estate Equities (ARE), Ford (F) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Maiden Holdings, Ltd. (MHLD)

179.6% sales growth and 5.16% return on equity

Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty reinsurance solutions to regional and specialty insurers in Europe, the United States, and internationally.

Maiden Holdings, Ltd.’s sales growth this year is expected to be 231.6% and a negative 0% for next year.

Year-on-year quarterly revenue growth declined by 46.5%, now sitting on 113.35M for the twelve trailing months.

Volume

Today’s last reported volume for Maiden Holdings, Ltd. is 32039 which is 58.99% below its average volume of 78125.

Maiden Holdings, Ltd.’s sales growth for the next quarter is 179.6%. The company’s growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.16%.

Volatility

Maiden Holdings, Ltd.’s last day, last week, and last month’s current intraday variation average was 0.34%, 0.94%, and 1.55%, respectively.

Maiden Holdings, Ltd.’s highest amplitude of average volatility was 2.37% (day), 2.90% (last week), and 3.05% (last month), respectively.

Maiden Holdings, Ltd.’s Stock Yearly Top and Bottom Value

Maiden Holdings, Ltd.’s stock is valued at $2.98 at 05:22 EST, way below its 52-week high of $4.00 and way above its 52-week low of $2.13.

Maiden Holdings, Ltd.’s Moving Average

Maiden Holdings, Ltd.’s worth is under its 50-day moving average of $3.12 and below its 200-day moving average of $3.29.

2. Alexandria Real Estate Equities (ARE)

31.8% sales growth and 7.21% return on equity

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500 urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $27.7 billion as of June 30, 2020, and an asset base in North America of 43.0 million square feet ("SF").

Alexandria Real Estate Equities’s sales growth this year is anticipated to be 6.6% and 12.6% for next year.

Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 2.02B for the twelve trailing months.

Volume

Today’s last reported volume for Alexandria Real Estate Equities is 1019020 which is 38.78% above its average volume of 734238.

Alexandria Real Estate Equities’s sales growth is a negative 0% for the present quarter and 31.8% for the next. The company’s growth estimates for the current quarter and the next is a negative 1.6% and negative -82.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.21%.

Volatility

Alexandria Real Estate Equities’s last day, last week, and last month’s current intraday variation average was 0.20%, 0.23%, and 0.57%, respectively.

Alexandria Real Estate Equities’s highest amplitude of average volatility was 0.76% (day), 1.08% (last week), and 1.53% (last month), respectively.

Alexandria Real Estate Equities’s Stock Yearly Top and Bottom Value

Alexandria Real Estate Equities’s stock is valued at $210.28 at 05:22 EST, below its 52-week high of $213.25 and way higher than its 52-week low of $154.37.

Alexandria Real Estate Equities’s Moving Average

Alexandria Real Estate Equities’s value is higher than its 50-day moving average of $204.10 and way above its 200-day moving average of $190.71.

3. Ford (F)

20.8% sales growth and 10.4% return on equity

Ford Motor Company designs, manufactures, markets, and services a range of Ford cars, trucks, sport utility vehicles, electrified vehicles, and Lincoln luxury vehicles worldwide.

Ford’s sales growth this year is expected to be 11.9% and 20.8% for next year.

Year-on-year quarterly revenue growth grew by 38.1%, now sitting on 136.43B for the twelve trailing months.

Volume

Today’s last reported volume for Ford is 122471000 which is 17.19% above its average volume of 104500000.

Ford’s sales growth is a negative 0% for the ongoing quarter and 20.8% for the next. The company’s growth estimates for the current quarter and the next is a negative 58.5% and negative -8.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.4%.

Volatility

Ford’s last day, last week, and last month’s current intraday variation average was 0.68%, 1.20%, and 2.12%, respectively.

Ford’s highest amplitude of average volatility was 4.67% (day), 4.47% (last week), and 3.66% (last month), respectively.

Ford’s Stock Yearly Top and Bottom Value

Ford’s stock is valued at $25.19 at 05:22 EST, way above its 52-week high of $20.51.

Ford’s Moving Average

Ford’s value is way higher than its 50-day moving average of $16.00 and way higher than its 200-day moving average of $14.22.

Previous days news about Ford(F)

  • According to Benzinga on Thursday, 13 January, "The need for lithium metal anode production will be critical in the coming years as legacy automakers such as General Motors Co (NYSE: GM), Ford Motor Co (NYSE: F), Volkswagen Group(OTC: VWAGY) rush to catch up with the industry disruptor Tesla Inc (NASDAQ: TSLA)."

4. Century Communities (CCS)

17.1% sales growth and 30.54% return on equity

Century Communities, Inc., together with its subsidiaries, engages in the design, development, construction, marketing, and sale of single-family attached and detached homes.

Century Communities’s sales growth this year is expected to be 35% and 12.2% for next year.

Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 4B for the twelve trailing months.

Volume

Today’s last reported volume for Century Communities is 49020 which is 84.53% below its average volume of 316900.

Century Communities’s sales growth for the next quarter is 17.1%. The company’s growth estimates for the ongoing quarter and the next is 132.4% and 40%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.54%.

Volatility

Century Communities’s last day, last week, and last month’s current intraday variation average was 0.80%, 1.20%, and 2.59%, respectively.

Century Communities’s highest amplitude of average volatility was 2.29% (day), 2.17% (last week), and 3.86% (last month), respectively.

Century Communities’s Stock Yearly Top and Bottom Value

Century Communities’s stock is valued at $80.64 at 05:22 EST, under its 52-week high of $86.07 and way higher than its 52-week low of $40.82.

Century Communities’s Moving Average

Century Communities’s worth is way higher than its 50-day moving average of $73.29 and way above its 200-day moving average of $68.80.

5. Illumina (ILMN)

13.6% sales growth and 11.86% return on equity

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis.

Illumina’s sales growth this year is expected to be 34% and 11.5% for next year.

Year-on-year quarterly revenue growth grew by 39.5%, now sitting on 4.28B for the twelve trailing months.

Volume

Today’s last reported volume for Illumina is 1736890 which is 78.31% above its average volume of 974065.

Illumina’s sales growth for the next quarter is 13.6%. The company’s growth estimates for the current quarter and the next is 10.8% and negative -33.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.86%.

Volatility

Illumina’s last day, last week, and last month’s current intraday variation average was 1.41%, 5.32%, and 2.16%, respectively.

Illumina’s highest amplitude of average volatility was 5.78% (day), 6.19% (last week), and 3.63% (last month), respectively.

Illumina’s Stock Yearly Top and Bottom Value

Illumina’s stock is valued at $405.14 at 05:22 EST, way under its 52-week high of $555.77 and way higher than its 52-week low of $341.03.

Illumina’s Moving Average

Illumina’s value is above its 50-day moving average of $391.10 and below its 200-day moving average of $426.55.

6. Proto Labs (PRLB)

8.4% sales growth and 4.28% return on equity

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide.

Proto Labs’s sales growth this year is expected to be 10.9% and 8.1% for next year.

Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 469.72M for the twelve trailing months.

Volume

Today’s last reported volume for Proto Labs is 239695 which is 55.95% below its average volume of 544219.

Proto Labs’s sales growth for the next quarter is 8.4%. The company’s growth estimates for the ongoing quarter and the next is a negative 46% and negative -5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.28%.

Volatility

Proto Labs’s last day, last week, and last month’s current intraday variation average was 2.20%, 0.75%, and 2.26%, respectively.

Proto Labs’s highest amplitude of average volatility was 3.22% (day), 2.76% (last week), and 4.20% (last month), respectively.

Proto Labs’s Stock Yearly Top and Bottom Value

Proto Labs’s stock is valued at $51.35 at 05:22 EST, way under its 52-week high of $286.57 and above its 52-week low of $47.57.

Proto Labs’s Moving Average

Proto Labs’s worth is under its 50-day moving average of $56.36 and way under its 200-day moving average of $80.34.

7. Amedisys (AMED)

6.2% sales growth and 25.99% return on equity

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.

Amedisys’s sales growth this year is expected to be 6.5% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 1.7%, now sitting on 2.21B for the twelve trailing months.

Volume

Today’s last reported volume for Amedisys is 279161 which is 34.18% below its average volume of 424139.

Amedisys’s sales growth for the next quarter is 6.2%. The company’s growth estimates for the current quarter and the next is a negative 20.8% and negative -16.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.99%.

Volatility

Amedisys’s last day, last week, and last month’s current intraday variation average was 1.18%, 1.59%, and 2.08%, respectively.

Amedisys’s highest amplitude of average volatility was 3.29% (day), 3.43% (last week), and 3.81% (last month), respectively.

Amedisys’s Stock Yearly Top and Bottom Value

Amedisys’s stock is valued at $165.63 at 05:22 EST, way below its 52-week high of $325.12 and way higher than its 52-week low of $133.62.

Amedisys’s Moving Average

Amedisys’s worth is higher than its 50-day moving average of $163.85 and way below its 200-day moving average of $212.14.

LEAVE A REPLY

Please enter your comment!
Please enter your name here